Table I.
Demographic and clinicopathological information of the patients.
| Feature | Group (n=21) | Microarray assay (n=6) (%) | PCR (n=15) (%) | Reverse transcription-quantitative P-value |
|---|---|---|---|---|
| Age | 0.94 | |||
| <60 | 3 (14.3) | 9 (42.9) | ||
| ≥60 | 3 (14.3) | 6 (28.5) | ||
| Sex | 0.61 | |||
| Female | 2 (9.5) | 5 (23.8) | ||
| Male | 4 (19) | 10 (47.6) | ||
| Differentiation | 0.83 | |||
| Low | 2 (9.5) | 6 (28.5) | ||
| Middle and high | 4 (19) | 9 (42.9) | ||
| TNM | 0.82 | |||
| T1+T2 | 1 (4.8) | 5 (23.8) | ||
| T3+T4 | 5 (23.8) | 10 (47.6) | ||
| Stage | 0.73 | |||
| I+II | 3 (14.3) | 8 (38.1) | ||
| III | 3 (14.3) | 7 (33.3) | ||
| Metastasis | 0.83 | |||
| No | 4 (19) | 9 (42.9) | ||
| Yes | 2 (9.5) | 6 (28.5) |